Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.48%556.7B | 18.58%594.06B | 3.25%596.8B | -6.84%2.17T | -9.91%563.87B | -12.90%522.84B | -18.28%500.99B | 19.08%578.01B | 86.81%2.32T | 58.40%625.92B |
Cost of revenue | -0.27%228.57B | 18.86%234.66B | 4.64%238.52B | -5.24%893.93B | -8.64%239.38B | -2.08%229.18B | -11.04%197.42B | 1.14%227.95B | 65.83%943.41B | 42.91%262.03B |
Gross profit | 11.74%328.13B | 18.39%359.4B | 2.35%358.28B | -7.93%1.27T | -10.83%324.49B | -19.81%293.66B | -22.39%303.57B | 34.64%350.06B | 104.49%1.38T | 71.81%363.89B |
Operating expense | -51.91%26.78B | 142.28%66.72B | 16.16%28.67B | 11.19%149.92B | 25.90%42.01B | 59.74%55.69B | -21.36%27.54B | -21.87%24.68B | 59.02%134.84B | 41.91%33.37B |
Selling and administrative expenses | 18.32%39.86B | 13.63%27.47B | 23.98%32.34B | 2.67%108.46B | -10.30%24.51B | 34.26%33.69B | -14.00%24.17B | 3.88%26.08B | 34.83%105.63B | 29.43%27.32B |
-General and administrative expense | 18.32%39.86B | 13.63%27.47B | 23.98%32.34B | 2.67%108.46B | -10.30%24.51B | 34.26%33.69B | -14.00%24.17B | 3.88%26.08B | 34.83%105.63B | 29.43%27.32B |
Other operating expenses | -65.92%2.66B | 646.43%46.85B | -13.64%8.53B | 42.00%41.47B | 189.39%17.51B | -20.02%7.81B | -9.12%6.28B | 52.37%9.87B | 353.10%29.2B | 151.31%6.05B |
Total other operating income | --15.75B | 160.83%7.6B | 8.14%12.19B | ---- | ---- | ---- | --2.91B | --11.27B | ---- | ---- |
Operating profit | 26.63%301.35B | 6.03%292.68B | 1.30%329.61B | -9.99%1.12T | -14.54%282.47B | -28.18%237.97B | -22.49%276.03B | 42.45%325.37B | 111.02%1.25T | 75.54%330.52B |
Net non-operating interest income (expenses) | 122.49%17.19B | -79.64%20.32B | -392.86%-7.18B | 21.97%39.41B | -12.05%13.58B | -843.16%-76.43B | 6,248.92%99.81B | -51.05%2.45B | 86.03%32.31B | 182.82%15.45B |
Non-operating interest income | 140.81%30.05B | -59.36%48.68B | 57.22%34.13B | 47.46%95.39B | -2.68%27.54B | -470.53%-73.65B | 1,449.86%119.79B | 147.11%21.71B | 107.90%64.69B | 219.79%28.3B |
Non-operating interest expense | 361.44%12.87B | 41.88%28.35B | 114.51%41.3B | 72.90%55.98B | 8.57%13.96B | -70.93%2.79B | 224.57%19.98B | 409.80%19.26B | 135.53%32.38B | 279.37%12.85B |
Net investment income | -8.56%36.46B | -18.02%18.23B | 5,237.88%39.87B | 416.64%22.24B | ||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 116.51B | -74.21%21.49B | 0 | 83.31B | ||||||
Income from associates and other participating interests | -29.16%16.66B | 162.63%27.29B | 2.18%50.49B | -75.30%40.92B | -74.74%11.56B | 27.29%23.51B | -164.96%-43.57B | 43.70%49.42B | 326.65%165.68B | 27.22%45.76B |
Special income (charges) | -253.64%-91.24B | -81.16%-13.63B | -82.07%-25.8B | -7.53B | ||||||
Less:Write off | ---- | ---- | ---- | 253.64%91.24B | 81.16%13.63B | ---- | ---- | ---- | 82.07%25.8B | --7.53B |
Other non-operating income (expenses) | 94.09%-2.5B | 109.31%7.74B | -521.92%-42.28B | -2,170.13%-83.06B | ||||||
Income before tax | 59.27%335.2B | 2.42%340.29B | -1.14%372.92B | -10.93%1.26T | -16.04%341.44B | -45.08%210.46B | -4.61%332.27B | 35.70%377.24B | 120.09%1.42T | 88.12%406.69B |
Income tax | 27.05%242.55B | 9.49%252.92B | 11.58%249.34B | -7.51%880.06B | 17.46%234.68B | -37.63%190.91B | -11.57%231.01B | 21.21%223.47B | 121.52%951.51B | 53.57%199.8B |
Net income | 373.85%92.64B | -13.71%87.37B | -19.63%123.58B | -17.94%381.34B | -48.40%106.76B | -74.63%19.55B | 16.25%101.26B | 64.23%153.77B | 117.22%464.69B | 140.33%206.89B |
Net income continuous operations | 373.83%92.64B | -13.71%87.37B | -19.63%123.58B | -17.94%381.34B | -48.40%106.76B | -74.63%19.55B | 16.25%101.26B | 64.23%153.77B | 117.22%464.69B | 140.33%206.89B |
Noncontrolling interests | 228.02%15.81B | -674.83%-3.39B | -74.85%1.75B | 170.83%9.8B | 25.18%15.62B | -126.78%-12.35B | 85.78%-437M | 2,162.13%6.97B | 139.68%3.62B | 1,548.08%12.48B |
Net income attributable to the company | 140.87%76.84B | -10.76%90.76B | -17.01%121.83B | -19.42%371.53B | -53.12%91.14B | -61.34%31.9B | 12.77%101.69B | 56.22%146.8B | 106.71%461.07B | 127.84%194.41B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 140.87%76.84B | -10.76%90.76B | -17.01%121.83B | -19.42%371.53B | -53.12%91.14B | -61.34%31.9B | 12.77%101.69B | 56.22%146.8B | 106.71%461.07B | 127.84%194.41B |
Gross dividend payment | ||||||||||
Basic earnings per share | 151.81%62.65 | -7.08%72.36 | -13.86%96.82 | -14.92%287.05 | -50.16%71.9 | -58.72%24.88 | 19.69%77.87 | 65.86%112.4 | 119.26%337.37 | 142.27%144.27 |
Diluted earnings per share | 152.84%62.61 | -7.07%72.31 | -13.86%96.76 | -14.94%286.8473 | -50.16%71.9 | -58.91%24.7625 | 19.60%77.81 | 65.75%112.33 | 119.16%337.2235 | 142.27%144.27 |
Dividend per share | 0 | 16.22%43 | 0 | 19.35%74 | 15.63%37 | 0 | 23.33%37 | 0 | 29.17%62 | 14.29%32 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |